RT Journal Article
SR Electronic
T1 Prediction of depressive symptoms based on sleep quality, anxiety, and brain structure
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.08.09.23293887
DO 10.1101/2023.08.09.23293887
A1 Olfati, Mahnaz
A1 Samea, Fateme
A1 Faghihroohi, Shahrooz
A1 Balajoo, Somayeh Maleki
A1 Genon, Sarah
A1 Patil, Kaustubh
A1 Eickhoff, Simon B.
A1 Tahmasian, Masoud
YR 2023
UL http://medrxiv.org/content/early/2023/08/13/2023.08.09.23293887.abstract
AB Background Depressive symptoms are rising in the general population and can lead to depression years later, but the contributing factors are less known. Although the link between sleep disturbances and depressive symptoms has been reported, the predictive role of sleep on depressive symptoms severity (DSS) and the impact of anxiety and brain structure on their interrelationship at the individual subject level remain poorly understood.Methods Here, we used 1813 participants from three population-based datasets. We applied ensemble machine learning models to assess the predictive role of sleep, anxiety, and brain structure on DSS in the primary dataset (n = 1101), then we tested the generalizability of our findings in two independent datasets. In addition, we performed a mediation analysis to identify the effect of anxiety and brain structure on the link between sleep and DSS.Results We observed that sleep quality could predict DSS (r = 0.43, rMSE = 2.73, R2 = 0.18), and adding anxiety strengthened its prediction (r = 0.67, rMSE = 2.25, R2 = 0.45). However, brain structure (alone or along with sleep/anxiety) did not predict DSS. Importantly, out-of-cohort validations of our findings in other samples provided similar findings. Further, anxiety scores (not brain structure) could mediate the link between sleep quality and DSS.Conclusion Taken together, poor sleep quality and anxiety symptoms could predict DSS across three cohorts. We hope that our findings incentivize clinicians to consider the importance of screening and treating subjects with sleep and anxiety problems to reduce the burden of depressive symptoms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We used the public datasets from the Human Connectome Project (https://www.humanconnectome.org/) and the enhanced Nathan Kline Institute-Rockland sample (eNKI) (http://fcon_1000.projects.nitrc.org/indi/enhanced/).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors